MARLETT CHRISTOPHER A 13D and 13G filings for Cue Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-04-21 3:16 pm Sale | 2020-04-21 | 13D | Cue Biopharma, Inc. CUE | MARLETT CHRISTOPHER A | 1,357,821 4.870% | -98,602 (-6.77%) | Filing |